Kai Gao

Chief Technology Officer AsymBio

Seminars

Tuesday 4th November 2025
Development of Robust & Scalable Conjugation Process for Next-Generation ADCs
2:30 pm
  • Examining the evolution from stochastic to advanced site-specific conjugation and the critical impact on CMC process development and product quality
  • Addressing the heightened complexity of novel modalities, focusing on molecular design diversity, intricate reaction kinetics, intermediate stability, and analytical complexity
  • Presenting holistic strategies and case studies for novel construct conjugation process development, robust in-process control of critical intermediates, and advanced purification/analytics to ensure product quality and scalability

Kai Gao